Startseite GCKD
There has been little research on kidney disease progression in the past. The GCKD study is conducted to better understand the causes, course, risk factors and consequences of progressive kidney disease in order to open up new avenues for targeted diagnostic and therapeutic possibilities.
Many people are affected by chronic kidney disease. The progression from initial, mild symptoms to advanced stages of kidney disease and kidney failure often spans a considerable period of time, with the duration dependent on a number of factors..
The GCKD study has enrolled a total of 5217 participants diagnosed with chronic kidney disease (CKD) independent of the underlying presumed leading kidney disease; 169 nephrologists all over Germany have recruited participants leading to this large number.
The objective of the GCKD study is to prospectively monitor the course and complications of CKD over time in order to better understand the factors underlying the progression of CKD to kidney failure in order to protect future generations by offering a more targeted therapy.
The GCKD study is designed as one of the largest CKD cohort studies worldwide and among the first ones in Europe to prospectively monitor the course and complications of patients diagnosed with CKD of different etiologies with sufficient power to understand the relations between biomarkers, course, and complications.
